EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:753250 - apolizumab
| ChEBI ID | CHEBI:753250 |
| ChEBI Name | apolizumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Application: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| apolizumab (CHEBI:753250) has role antineoplastic agent (CHEBI:35610) |
| apolizumab (CHEBI:753250) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| Apolizumab | ChEMBL |
| HU-1D10 | ChEMBL |
| HU1D10 | ChEMBL |
| Remitogen | ChEMBL |
| Brand Name | Source |
|---|---|
| Remitogen smart1d10 | ChEMBL |